pyridoxamine hydrochloride
- Generic Name
- pyridoxamine hydrochloride
Pyridorin in Diabetic Nephropathy
Phase 3
Terminated
- Conditions
- Diabetic NephropathyDiabetic Kidney Disease
- Interventions
- Drug: Placebo
- First Posted Date
- 2014-06-05
- Last Posted Date
- 2016-03-09
- Lead Sponsor
- NephroGenex, Inc.
- Target Recruit Count
- 328
- Registration Number
- NCT02156843
- Locations
- 🇺🇸
CSG Investigational Site (#160), Los Angeles, California, United States
🇺🇸CSG Investigational Site (#143), Riverside, California, United States
🇺🇸CSG Investigational Site (#113), Chicago, Illinois, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath